With 6.1% CAGR, Impact of COVID-19 on Pharmaceuticals Market Size Worth USD 2,401.22 Billion by 2029

Wednesday, November 2, 2022 at 9:18am UTC

Pune, India, Nov. 02, 2022 (GLOBE NEWSWIRE) -- The global Impact of COVID-19 on Pharmaceuticals Market size was valued at USD 1,494.67 billion in 2021. The market is expected to grow from USD 1,585.05 billion in 2022 to USD 2,401.22 billion by 2029, exhibiting a CAGR of 6.1% during 2022-2029. Increasing healthcare investments and rapid digital technology adoption are expected to fuel market growth. Fortune Business Insights™ shares this information in its report titled “Impact of COVID-19 on Pharmaceuticals Market, 2022-2029.”

Key Industry Developments

  • June 2022- Novartis AG received the European Commission approval for Tabrecta’s monotherapy for advanced non-small cell lung cancer treatment.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/impact-of-covid-19-on-pharmaceuticals-market-102685

Report Scope:

Report CoverageDetails
Forecast Period2022 to 2029
Forecast Period 2020 to 2027 CAGR6.1%
2029 Value ProjectionUSD 2,401.22 Billion
Base Year2021
Market Size in 2022USD 1,585.05 Billion
Historical Data for2018 to 2020
No. of Pages215

Drivers and Restraints

Rising Prevalence of Infectious Diseases to Foster Market Growth

Pharmaceuticals consist of drugs that are utilized for medical purposes. The rising prevalence of infectious diseases is expected to fuel the demand for pharmaceuticals. For example, in 2022, the American Cancer Society anticipated that 1.9 million new cancer cases were diagnosed in the U.S. Furthermore, rising per-capita incomes and developing health infrastructure are likely to enhance the product demand. Moreover, the robust demand for numerous drugs for therapeutic areas is expected to elevate research and development (R&D) investments. These factors may drive the impact of COVID-19 on the pharmaceuticals market growth.

However, product recalls and lawsuits against companies may hamper market progress.

Click here to get the short-term and long-term impact of COVID-19 on this market.

Please visit: https://www.fortunebusinessinsights.com/impact-of-covid-19-on-pharmaceuticals-market-102685

COVID-19 Impact

Disruptions in Supply Chain Slightly Hindered Industry Growth during the Pandemic

This market was slightly affected during the COVID-19 pandemic due to restrictions on manufacturing, thereby disrupting the supply chains. The sudden spike in COVID-19 infected patients enhanced the demand for effective drugs and medical equipment. Further, the disruptions in supply chains slightly affected the industry during the initial phase. However, manufacturers opted for industrial automation, part-time shifts, and reduced capacities to enhance their earnings, satisfy demands, and enhance their overall efficiency. This factor facilitated the industry’s growth during the pandemic.


Drugs Segment to Lead Attributable to Strong Demand for Chronic Disease Treatment

By type, the market is segmented into drugs and vaccines. The drugs segment is expected to lead due to its strong demand for chronic disease treatment.

Retail Pharmacies Segment to Hold Dominant Market Share Attributable to Availability of OTC Products

As per distribution channel, the market is trifurcated into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment is expected to dominate, attributable to the availability of OTC products.

Regionally, the market is clubbed into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Quick Buy - Impact of COVID-19 on Pharmaceuticals Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102685

Report Coverage

The report provides a detailed analysis of the top segments and the latest trends in the market. It comprehensively discusses the driving and restraining factors and the impact of COVID-19 on the market. Additionally, it examines the regional developments and the strategies undertaken by the market's key players.

Regional Insights

Technological Advancements in Clinical Trials to Foster Market Growth in North America

North America is expected to dominate the pharmaceuticals market share due to technological advancements in clinical trials. The market in North America stood at USD 610.29 billion in 2021 and is expected to gain a huge portion of the global market share in the coming years. Furthermore, manufacturers launch several products to cater to consumer needs, thereby facilitating the industry’s progress.

In Europe, the rising awareness of diagnosis and treatment procedures is expected to foster the product demand. Furthermore, rapid R&D investments in the region are expected to fuel the industry’s growth.

In Asia Pacific, rising awareness regarding the management and care of disorders is expected to foster the demand for pharmaceuticals. These factors may elevate the industry’s growth in the region.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/impact-of-covid-19-on-pharmaceuticals-market-102685

Competitive Landscape

Major Players Enter into Collaborations to Elevate their Product Offerings

The prominent companies operating in the market enter into collaborations to enhance their product offerings. For example, Novo Nordisk A/S and Gilead Sciences, Inc. entered into a collaboration to clinically study Novo Nordisk’s semaglutide efficacy in March 2021. This strategy may allow companies to produce the best pharmaceuticals products, thereby elevating their brand image. Further, companies deploy research and development, acquisitions, mergers, and automation to elevate their market position.

List of Key Players Profiled in the Report

  • Pfizer Inc. (U.S.)
  • Johnson & Johnson Services Inc. (U.S.)
  • GSK plc. (U.K.)
  • Novartis AG (Switzerland)
  • Merck & Co., Inc. (U.S.)
  • Sanofi (France)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • AstraZeneca (U.K.)
  • Novo Nordisk A/S (Denmark)

Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Impact of COVID-19 on the Supply Chain
    • Key Industry Developments – In Response to the COVID-19 Impact
    • Key Regulatory and Reimbursement Changes
    • Disruption of R&D projects in the Pharmaceuticals space with examples for major products/companies
    • Shift of R&D focus form other projects to COVID-19 the Pharmaceuticals space with examples for major products/companies
    • Impact of COVID-19 on the overall R&D and development of new products in the healthcare market
  • Key Insights – Pharmaceuticals Market (General)
    • Clinical Trials in Pharmaceuticals Market - Number of Trials, Size of the Industry, Number of Participants, Number of Sites, R&D Spending of Major Companies, Economic Impact of Clinical Trials
    • Success Rate of Drugs - Average Time and Price to Get a Drug on the Market, Proportion of Drugs that are Successful and Reach Blockbuster Status
    • Risk & Opportunities in Development of New Drugs – Qualitative Insights
  • Global Pharmaceuticals Market Analysis, Insights and Forecast, 2018-2029
    • Market Analysis, Insights and Forecast – By Type
      • Drugs
        • Oncology
        • Diabetes
        • Infectious Diseases
        • Cardiology
        • Neurology
        • Respiratory
        • Hypertension
        • Others
      • Vaccines
        • Viral Diseases
        • Bacterial Diseases
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Analysis, Insights and Forecast – By Geography
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
  • North America Pharmaceuticals Market Analysis, Insights and Forecast, 2018-2029
    • Market Analysis, Insights and Forecast – By Type
      • Drugs
        • Oncology
        • Diabetes
        • Infectious Diseases
        • Cardiology
        • Neurology
        • Respiratory
        • Hypertension
        • Others
      • Vaccines
        • Viral Diseases
        • Bacterial Diseases
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Market Analysis, Insights and Forecast – By Country
      • U.S.
      • Canada

TOC Continued…..

Ask for Customization of this Report: https://www.fortunebusinessinsights.com/enquiry/customization/impact-of-covid-19-on-pharmaceuticals-market-102685

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

9th Floor, Icon Tower,

Baner - Mahalunge Road,

Baner, Pune-411045,

Maharashtra, India.


U.S: +1 424 253 0390

U.K.: +44 2071 939123

APAC: +91 744 740 1245

Primary Logo